We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+1.77%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$291B
AUM Growth
+$10.8B
Cap. Flow
-$1.99B
Cap. Flow %
-0.68%
Top 10 Hldgs %
25.57%
Holding
11,136
New
1,911
Increased
3,840
Reduced
3,666
Closed
1,619

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.29%
2 Technology 1.9%
3 Financials 1.28%
4 Communication Services 1.02%
5 Consumer Discretionary 0.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SGG
8151
DELISTED
iPath Series B Bloomberg Sugar Subindex Total ReturnSM ETN
SGG
$251K ﹤0.01%
+5,612
New +$251K
OUSM icon
8152
ALPS O'Shares US Small-Cap Quality Dividend ETF
OUSM
$855M
$250K ﹤0.01%
+9,223
New +$247K
RTH icon
8153
CALL
VanEck Retail ETF
RTH
$253M
$250K ﹤0.01%
2,500
-3,300
-57% -$320K
ENT
8154
DELISTED
Global Eagle Entertainment Inc.
ENT
$250K ﹤0.01%
+3,968
New +$173K
STML
8155
CALL
DELISTED
Stemline Therapeutics, Inc.
STML
$250K ﹤0.01%
15,600
-2,900
-16% -$51.8K
EUFL
8156
DELISTED
Direxion Daily European Financials Bull 2X Shares
EUFL
$250K ﹤0.01%
+7,088
New +$291K
USG
8157
DELISTED
Usg
USG
$250K ﹤0.01%
5,804
-194,421
-97% -$8.07M
SPHS
8158
PUT
DELISTED
Sophiris Bio, Inc.
SPHS
$250K ﹤0.01%
89,000
+63,000
+242% +$187K
EET icon
8159
PUT
ProShares Ultra MSCI Emerging Markets
EET
$38.7M
$249K ﹤0.01%
3,200
-7,700
-71% -$679K
MAS icon
8160
Masco
MAS
$14.4B
$249K ﹤0.01%
6,658
-72,779
-92% -$2.8M
MMYT icon
8161
CALL
MakeMyTrip
MMYT
$5.55B
$249K ﹤0.01%
+6,900
New +$248K
BEST
8162
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
$249K ﹤0.01%
+1,020
New +$234K
OQAL
8163
DELISTED
Invesco Russell 1000 Quality Factor ETF
OQAL
$249K ﹤0.01%
+9,051
New +$240K
MLNT
8164
CALL
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$249K ﹤0.01%
7,840
+3,360
+75% +$121K
EUO icon
8165
PUT
ProShares UltraShort Euro
EUO
$33.1M
$248K ﹤0.01%
+10,900
New +$238K
JPSE icon
8166
JPMorgan Diversified Return US Small Cap Equity ETF
JPSE
$596M
$248K ﹤0.01%
7,877
-4,840
-38% -$148K
KPTI icon
8167
PUT
Karyopharm Therapeutics
KPTI
$42.4M
$248K ﹤0.01%
973
-1,240
-56% -$307K
PTY icon
8168
PIMCO Corporate & Income Opportunity Fund
PTY
$2.5B
$248K ﹤0.01%
+14,182
New +$252K
SCHL icon
8169
PUT
Scholastic
SCHL
$735M
$248K ﹤0.01%
+5,600
New +$240K
SMMV icon
8170
iShares MSCI USA Small-Cap Min Vol Factor ETF
SMMV
$289M
$248K ﹤0.01%
+7,960
New +$240K
UIS icon
8171
CALL
Unisys
UIS
$196M
$248K ﹤0.01%
19,200
-16,500
-46% -$198K
VIS icon
8172
Vanguard Industrials ETF
VIS
$8.07B
$248K ﹤0.01%
1,827
-17,290
-90% -$2.41M
ROYT
8173
DELISTED
PACIFIC COAST OIL TRUST
ROYT
$248K ﹤0.01%
107,621
+22,911
+27% +$49.1K
IPHS
8174
PUT
DELISTED
Innophos Holdings, Inc.
IPHS
$248K ﹤0.01%
5,200
-1,000
-16% -$45.5K
MLNT
8175
PUT
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$248K ﹤0.01%
7,820
-9,440
-55% -$340K

Similar funds

Jeff Yass's Q2 2018 Portfolio in Review

As of Q2 2018, Jeff Yass held 11,136 positions worth $291B, up 3.8% from $281B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Jeff Yass's Q2 2018 filing shows 1,911 new, 3,840 increased, 3,666 reduced and 1,619 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 4,732,803 shares worth $300M. The largest sale was Meta Platforms (Facebook), an estimated $1.5B.

By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, up from 92% a quarter earlier, followed by Technology and Financials.

  • Jeff Yass's largest Q2 2018 buy was iShares Core MSCI EAFE ETF: 4,732,803 shares worth $300M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $696M increase.
  • Jeff Yass's biggest Q2 2018 reduction was Meta Platforms (Facebook), cutting an estimated $1.5B.
  • Jeff Yass fully exited iShares 0-1 Year Treasury Bond ETF in Q2 2018, selling an estimated $341M.
  • Jeff Yass's ten largest holdings make up 26% of its $291B portfolio in Q2 2018.
  • Jeff Yass opened 1,911 new positions and closed 1,619 in Q2 2018.
  • Jeff Yass's portfolio value rose 3.8% quarter-over-quarter to $291B.

Based on Susquehanna International Group's 13F filing for Q2 2018, filed 14 Aug 2018.